Back

Lp (a) as a target - Why and how

4 November 2023 (09:45 - 10:05)
Organised by: Logo
Seminar Presentation Part of: Evolving targets in lipid lowering therapy Cardiovascular Pharmacotherapy Open Access EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy WG on Cardiovascular Pharmacotherapy

About the speaker

Photo
Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)

2 More presentations in this session

Presentation thumbnail
New kids on the “therapeutic” block
Doctor M. Lettino (Monza, IT)
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
Evolving targets in lipid lowering therapy

The Event

Event poster

EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

4 November 2023 09:45 CET
You may be interested in
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023
thumbnail
Congress Presentation
GAELp(a): National Registry on Lp(a) and Cardiovascular Risk in Argentina
1 September 2025
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
25 November 2025
thumbnail
Congress Presentation
Correlations between elevated levels of lipoprotein A and the risk to develop heart failure after an acute coronary syndrome
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources